Search - tctmd.com

Displaying 301 - 320 of 576

Sort: Relevancy | Date

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

News Conference News AHA 2020

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Michael O'Riordan

November 13, 2020

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

News Daily News

CMR Picks Up Pericardial Inflammation in Student Athletes With COVID-19

Michael O'Riordan

November 06, 2020

News Daily News

Coronary Calcium Scans May ID Patients Who Benefit From Aspirin

Michael O'Riordan

October 30, 2020

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Conference News EAS 2020

Just One-Third of European Patients Get to LDL Cholesterol Goals

Michael O'Riordan

October 13, 2020

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

News Conference News EAS 2020

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Michael O'Riordan

October 07, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Michael O'Riordan

September 22, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Michael O'Riordan

September 02, 2020

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Daily News

Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin

Michael O'Riordan

August 25, 2020

News Daily News

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Michael O'Riordan

August 20, 2020

News Daily News

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Michael O'Riordan

August 14, 2020

Advertisement

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

CMR Picks Up Pericardial Inflammation in Student Athletes With COVID-19

Coronary Calcium Scans May ID Patients Who Benefit From Aspirin

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Just One-Third of European Patients Get to LDL Cholesterol Goals

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content